Contact Sentry at your convenience to discuss how Sentry can help optimize your solutions for biopharmaceutical product storage, distribution, packaging, project management and commercial fulfillment.
|
cGMP Facility | No 483s
Sentry BioPharma Services, Inc.
|
Contract Services for Temperature-Sensitive Clinical and Commercial Pharmaceutical Supply Chains
Sentry BioPharma Services provides FDA compliant packaging solutions and supply chain management services to global pharmaceutical, biotechnology and medical device firms. Drug development and commercialization require continuous temperature monitoring and control. Sentry's diverse offering protects product integrity throughout the pharmaceutical supply chain.
Sentry's validated software, GMP storage and distribution facility, industry expertise and stringent quality standards support this objective throughout manufacturing, packaging, storage and distribution.
All biopharmaceutical contract service providers must provide exceptional quality records and superior customer service–
What sets Sentry apart?
- Designed and built to support cGMP operations including packaging, storage, and distribution for life science products
- Client-focused culture promotes responsiveness
- Contract manufacturing & packaging expertise
- Robust range of processes & services allows client-specific solutions
|
Sentry Provides
|
Sentry Serves
- Biotechnology and pharmaceutical manufacturers
- Medical device manufacturers
- Contract service organizations (CMO, CRO)
- Hospitals and pharmacies
- Governments and universities
|
| |
|
Sentry Protects
|
Sentry Supports
|
Discover how Sentry's product guardianship applies to your exacting requirements - and how Sentry BioPharma Services differs from other contract service providers. Consult our FAQs here, call 1.317.856.5889 (toll free 1.866.757.7400) or contact us via email.
-
December 06, 2011 - Sentry BioPharma Services Proudly Announces Successful Completion of Routine FDA General Inspection – No 483 Observations
On Tuesday, December 6, 2011, the U.S. Food and Drug Administration (“FDA”) conducted a routine general inspection of Sentry BioPharma Services’ Indianapolis biopharmaceutical clinical and commercial labeling , packaging, kitting, warehousing and distribution GMP facility. At the conclusion of the visit, the FDA closed the inspection with no 483 violations issued or areas of noncompliance identified.
-
November 05, 2011 - Sentry BioPharma Services Completes Triennial Verified Accredited Wholesaler Distributor® (VAWD®) Re-accreditation
Sentry BioPharma Services’ regulatory team proudly announced the successful completion of Sentry’s triennial Verified Accredited Wholesaler Distributor® (VAWD®) re-accreditation process today.
-
October 18, 2011 - Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X
Sentry BioPharma Services enhances its ability to secure government service contracts for temperature-controlled vaccine and pharmaceutical storage and biopharmaceutical logistics.
-
October 17, 2011 - Sentry BioPharma Services Passes Routine IPLA Inspection – No Observations
On Friday, October 14, 2011, the Indiana Professional Licensing Agency (“IPLA”) completed a routine, unannounced inspection of Sentry BioPharma Services’ Indianapolis biopharmaceutical warehousing and distribution facility.
-
October 05, 2011 - Vetter’s State-of-the-Art Chicago Facility Is Now Fully Operational
Vetter announced today that all production capabilities are now fully operational at the Vetter's new clinical development site in the Illinois Science + Technology Park in Skokie—including a state-of-the-art Bosch MHI 2020B fully automated vial filler.
More News...
|
-
January 31, 2012 - World Pharma Innovation Congress USA 2012
The World Pharma Innovation Congress USA provides an unrivalled platform to revolutionize open innovation for the drug industry. Discussing business, external technology sourcing, talent management and successful corporate open innovation models, it is the perfect opportunity to identify and approach new business prospects.
-
February 27, 2012 - IBC's 2012 Biopharmaceutical Development & Production Week
-
April 10, 2012 - World Vaccine Congress 2012
The 12th Annual World Vaccine Congress in Washington, DC brings new scientific and business critical debate, discussion and solutions from the true global pioneers shaping vaccine R&D.
Facilitating executive level commentary, communication and partnerships between the industry’s elite, World Vaccine Congress 2012 is where leaders of the world’s vaccine community meet to influence and evolve the future of the vaccine industry.
-
May 20, 2012 - 2012 TIDES: Oligonucleotide and Peptides®
TIDES: Oligonucleotide and Peptides® Research, Technology and Product Development. The only industry event for full coverage of the oligonucleotide and peptide market.
-
May 21, 2012 - 2012 National Biotechnology Conference
2012 APS National Biotechnology Conference - Advancing Health Through Innovations in Biotherapeutics
More Events...
|
|